Archive
Edition 16 - AI at Work: Differential Performance, Validated Decisions, and Nuclear Medicine's Precision Promise
Discover how LLMs boost novice MRI readers by 19 percentage points but barely move expert neuroradiologists, explore the first FDA-cleared AI tool for breast cancer treatment selection validated against RCT data at ASCO, and learn how AI-guided patient selection is being positioned to define the next era of radioconjugate therapy in nuclear medicine.
Edition 15 - Autonomy, Accountability, and the Algorithm: Who Decides When AI Reads Alone?
Discover why a hospital CEO's call to replace radiologists is more regulatory challenge than clinical breakthrough, explore how the EU just quietly rewrote the rulebook for AI medical devices, and learn how a Lancet Oncology pathology model could make Oncotype DX redundant in clinics that can't afford it.












